Trial Profile
A Phase 2 Study of Suberoylanilide Hydroxamic Acid (SAHA) in Subjects With Locally Advanced, Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Vorinostat (Primary)
- Indications Adenoid cystic carcinoma; Salivary gland cancer
- Focus Therapeutic Use
- 10 Sep 2018 Status changed from active, no longer recruiting to completed.
- 15 Sep 2017 Planned primary completion date changed from 1 Dec 2016 to 31 Dec 2018.
- 09 Dec 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov.